68.97BMarket Cap15.71P/E (TTM)
173.50High161.10Low15.08KlotVolume161.10Open161.98Pre Close257.11MTurnover1.67%Turnover RatioLossP/E (Static)401.00MShares215.7152wk High13.38P/B15.56BFloat Cap76.3252wk Low194.38Limit Up90.45MShs Float215.71Historical High129.58Limit Down7.66%Amplitude28.75Historical Low--Dividend TTM170.54Avg Price4.99KlotAsk--Div YieldTTM100Lot Size8.49KlotBid
Sichuan Biokin Pharmaceutical Stock Forum
December 22, 2023
2142.HK
1.56
(-2.5%)
The biopharma company has marked out a path to profitability by licensing its drug expertise and antibody platforms to partners such as Pfizer
Key Takeaways:
Nona Biosciences, a subsidiary of HBM Holdings, has struck a licensing-out deal with a Pfizer-owned biotech for an initial sum of $53 million and milestone payments of up to $1.05 billion
HBM Holdin...
No comment yet